Impact Factor for Five Years is 1.55 (2012 - 2016). 22nd National Convention of Society of Pharmacognosy & International Conference. For more details visit https://ncsp.ganpatuniversity.ac.in/index.php

logo

INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH

A Step Towards Excellence

IJPR included in UGC-Approved List of Journals - Ref. No. is SL. No. 4812 & J. No. 63703

ISSN
0975-2366
5 - Years Impact Factor

Year 2012 - 2016

Impact Factor: 1.55

Total Publications: 317

Total Citation: 491

Year 2011 - 2015

Impact Factor: 1.46

Total Publications: 326

Total Citation: 477

Year 2010 - 2014

Impact Factor: 1.3

Total Publications: 313

Total Citation: 407

Year 2009 - 2013

Impact Factor: 0.973

Total Publications: 293

Total Citation: 285

Current Issue
Article In Press
Antioxidant activity and total phenolic content in 15 commonly used cucurbits in Tarai region of Kumaun, Uttarakhand.
Analytical Method Development and Validation for the Simultaneous Estimation of Ambroxol Hydrochloride and Guaiphenesin in Syrup Dosage form by RP-HPLC
Role of NMDA receptor antagonist in ethanol withdrawal syndrome
STABILITY INDICATING LC-MS/MS METHOD FOR QUANTIFICATION OF IBRUTINIB IN HUMAN PLASMA
A review on drug: Amantadine
Chemopreventive and antioxidative activity of Carissa carandas extract against chemical induced skin tumorigenesis in mice
ROLE OF AMIODARONE IN ACUTE MYOCARDIAL INFARACTION INDUCED VENTRICULAR TACHYCARDIA IN PATIENTS WITH LEFT ANTERIOR DESCENDING ARTERY INVOLVEMENT
Extraction optimisation, fractionation, standardisation, in vitro antioxidant and anticholinesterase activity of fractions of Indian Propolis
Development of validated stability-indicating analytical method for simultaneous estimation of Atenolol and Hydrochlorothiazide in pharmaceutical combined dosage form by High Performance Thin Layer Chromatography.
Lung Cancer in Lifelong Never Smokers-Short Review
12
ADOBE READER

(Require Adobe Acrobat Reader to open, If you don't have Adobe Acrobat Reader)

Index Page 1
Click here to Download
IJPRT ISSUE

January - March 6 [1] 2014

Click to download
 

Article Detail

Label
Lung Cancer in Lifelong Never Smokers-Short Review

Author: KIRTI SHARMA
Abstract: Occurrence of lung cancer in lifelong never smokers has been increased worldwide and most common cause of mortality was reported due to only lung cancer across the world. Lung cancer that occurs in never smokers is reported different from active smokers in terms of their molecular profile and response of chosen targeted therapies to combat lung cancer. Many genetic, hormonal and environmental factors were found responsible for the risk of lung cancer in never-smokers as per the available data on its clinical epidemiology that implicate its aetiology. Recently, the selected therapeutic approaches using EGFR-TK inhibitor, ALK inhibitor and HGFR or c-MET inhibitors were suggested to treat this disease as remarkable molecular targeted therapies which has been successfully proposed as more competent to suppress oncogenes in lifelong never smokers lung cancer patients.
Keyword: Lung cancer; Lifelong never smokers; EGFR-TK inhibitor; ALK inhibitor; c-MET inhibitors
Download: Request For Article
 
INDEXED
Chemical Abstract Services
Scopus (Elsevier) (Re-Application is Under Process)
Embase(Elsevier)
Ulrich's International Periodical Dictionary
Indian Science Abstract
USER LOGIN
Username
Password
Login | Register
Forgot your password?
News & Events
22nd National Convention of Society of Pharmacognosy & International Conference. For more details visit https://ncsp.ganpatuniversity.ac.in
Impact Factor for five years is 1.55 (2012 - 2016)
Year 2011 - 2015 Impact Factor - 1.46 Total Publications - 326 Total Citations - 477
Impact Factor for five years is 1.3 (2010 - 2014)